Three nuclear transcription factors regulating cholesterol metabolism have been linked to NAFLD: sterol regulatory element-binding protein (SREBP-2), farnesoid X receptor (FXR), and liver X receptor (LXR) [33]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.